News & Updates

Vaccine-preventable diseases cause most hospitalizations in IBD patients
Vaccine-preventable diseases cause most hospitalizations in IBD patients
24 Sep 2022
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
23 Sep 2022
Having regular meals helps prevent IBS in adults
Having regular meals helps prevent IBS in adults
21 Sep 2022

Individuals who observe a regular meal pattern are less likely to have irritable bowel syndrome (IBS), IBS-mixed, and the syndrome severity, a study has shown. Meal regularity is also associated with lower IBS prevalence in women and in those with normal weight.

Having regular meals helps prevent IBS in adults
21 Sep 2022
Proximal gastrectomy OK for proximal advanced gastric cancer
Proximal gastrectomy OK for proximal advanced gastric cancer
16 Sep 2022

For patients with proximal advanced gastric cancer (AGC), proximal gastrectomy (PG) appears to be a reasonable treatment option, particularly for those with small tumours, a recent study has found.

Proximal gastrectomy OK for proximal advanced gastric cancer
16 Sep 2022
Hypophosphatemia events more frequent with ferric carboxymaltose vs ferric derisomaltose
Hypophosphatemia events more frequent with ferric carboxymaltose vs ferric derisomaltose
16 Sep 2022
Any upside to frontline mFOLFOXIRI-panitumumab in mCRC?
Any upside to frontline mFOLFOXIRI-panitumumab in mCRC?
14 Sep 2022 byRoshini Claire Anthony

In patients with unresectable RAS and BRAF wildtype metastatic colorectal cancer (mCRC), a modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN*) treatment strategy in the first-line setting did not improve objective response rate (ORR) compared with FOLFOX plus panitumumab (mFOLFOX6/PAN**), results of the phase III TRIPLETE study showed.

Any upside to frontline mFOLFOXIRI-panitumumab in mCRC?
14 Sep 2022